Ernst Timothy S's Form 4 filing
Bio-Rad Laboratories, Inc. (BIO) · filed Feb 29, 2024
- Accession no.
- 0001062993-24-004959
- Filed
- Feb 29, 2024
- Trade date
- Feb 28, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $826.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ernst Timothy SCIK 0001676291 | Officer (EVP, General Counsel & Sec) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Bio-Rad A Common Stock | MOption exerciseAcquired | +2,500 | $326.15 | +$815,375 | 5,897.48 | Direct | |
| Feb 28, 2024 | Bio-Rad A Common Stock | SSaleDisposed | −2,500 | $330.55 | −$826,375 | 3,397.48 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Bio-Rad A Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.